Orforglipron (Eli Lilly): The Oral Option Eli Lilly is also developing orforglipron, an oral (pill) GLP-1 agonist
GLP-1 Analogues vs Traditional Antidiabetic Drugs Source: Polaris Market Research Analysis GLP-1 Analogues Market Trends Rising Geriatric Population Older individuals, due to age-related factors, are at a higher risk of developing type 2 diabetes and related health conditions, resulting in a greater need for GLP-1 analogues inhibitors
More practically relevant: tell any clinician treating you, including before planned surgery, that you take it, since slowed stomach emptying matters for anaesthesia and fasting instructions, and the effect persists for weeks after a last dose
What follows is the part the coverage skips: what the research on these four drugs actually shows
One of the reported semaglutide cases had a history of previously using dulaglutide